We are inviting experts of the Chinese pharmaceutical/healthcare sector to submit proposals for 30 minute presentation slots at our highly-respected Pharma China annual events in Shanghai (March 18, 2016) and Princeton, NJ (April 22, 2016). 

Please note that our stringent selection of speakers is entirely based on merits of presentation topics and presenter expertise, and is not linked with sponsorship in anyway. Sponsorship does not ensure availability of speaker slots. This ensures the highest quality of our well-respected annual events which has been held annually in the past eight years.

Speakers will receive free admission to the event, speaker intro/logo display via our brochure and agenda, display of promotional materials at event site, as well as high quality exposure and the opportunity to be complemented and challenged face-to-face by our high-caliber participants and fellow speakers.

These events are usually attended at between 50-60 mid-level and senior executives of MNC pharma companies who are based in Shanghai and from HQs. Attached please find our draft brochure for the Shanghai event, which is not completed, for your information. For more information on our NJ event, please visit www.pharmachinaseminar.com, for more information.

 

Event: Pharma China Annual Forum 2016 – Confronting Healthcare Challenges in China
Organizer: Pharma China

Date: March 18, 2016

Venue: Le Royal Meridien Shanghai, China

 

Event: Pharma China Seminar 2016 - Building Success in China's Pharma Sector
Date: April 22, 2016

Venue: TBD, Princeton, New Jersey

 

 

- Government affairs/market access/regulatory issues in Chinese pharma

- Reform of Chinese drug evaluation and approval framework and far-reaching impacts

- Pharma R&D trends and strategies in China

- Pharma IP/Legal issues/Compliance

- MNC China strategies in the new era / Reform of pharma sales and marketing models in China

- Chinese healthcare reform developments, trends, issues and challenges

- Healthcare trends/patient demographics/physician practices in China

- Evolvement of private insurance and its impact from patients and company’s perspective;

- Pharma e-Commerce, mobile/online healthcare and impacts on Chinese pharma

- New trends in Chinese healthcare communications and public relations by drug companies

- Globalization trends of Chinese companies in generic drugs and APIs

- Sourcing from China / CMOs

- Other suggested expertise areas of high value to the pharma industry in China

 

Please send your presentation proposal with title, a few lines of content highlights, choice of events and any comments to James Shen (jshen@pharmachinaonline.com or jshen.wicon@gmail.com) as soon as possible. We will let you know our decision around mid-January when we finish evaluating all proposals.

 

Publisher, Pharma China

WiCON International Group LLC

Email: jshen@pharmachinaonline.com or jshen.wicon@gmail.com